OrfoNeuro ApS: Financial statements 2019
CVR: 37768901
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
OrfoNeuro ApS (CVR 37768901) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK -145,897 and a net result of DKK -140,299 compared with DKK -165,775 the year before. Equity in the 2019 report amounted to DKK -263,141.
- Gross Profit
- DKK -145,897
- Profit/Loss
- DKK -140,299
- Equity
- DKK -263,141
- Total Assets
- DKK 151,824
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | -146 t. | -140 t. | -263 t. | 0 |
| 2018 | - | -204 t. | -166 t. | -123 t. | 0 |
| 2017 | - | -7 t. | -7 t. | 43 t. | 0 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
OrfoNeuro ApS has published its annual report for 2018. Gross profit came to DKK -203,713, and the net result was DKK -165,775.
About OrfoNeuro ApS
OrfoNeuro ApS is a Danish company of the type Anpartsselskab based in Lynge, founded in 2016. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Jens Morten Fogh. The board consists of Ulrik Spork (chair), Jens Morten Fogh and Per Toft Valstorp. The company is owned by VALSTORP & COMPANY ApS, JIMKKS Holding ApS and Claes Magnus Andersson. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -267,558 and a net result of DKK -289,729 compared with DKK -242,569 the year before. Equity in the 2025 report amounted to DKK 9,545.